TY - JOUR
T1 - Macrophage infiltration predicts a poor prognosis for human ewing sarcoma
AU - Fujiwara, Toshifumi
AU - Fukushi, Jun Ichi
AU - Yamamoto, Shunsaku
AU - Matsumoto, Yoshihiro
AU - Setsu, Nokitaka
AU - Oda, Yoshinao
AU - Yamada, Hisakata
AU - Okada, Seiji
AU - Watari, Kosuke
AU - Ono, Mayumi
AU - Kuwano, Michihiko
AU - Kamura, Satoshi
AU - Iida, Keiichiro
AU - Okada, Yuko
AU - Koga, Mihoko
AU - Iwamoto, Yukihide
PY - 2011/9
Y1 - 2011/9
N2 - Ewing sarcomaprimitive neuroectodermal tumor (EWS) is associated with the most unfavorable prognosis of all primary musculoskeletal tumors. The objective of the present study was to investigate whether tumor-associated macrophages (TAMs) affect the development of EWS. TAMs were isolated from mouse xenografts using CD11b magnetic beads and examined for their cytokine expression and osteoclastic differentiation. To evaluate the role of TAMs in xenograft formation, liposome-encapsulated clodronate was used to deplete TAMs in mice. Macrophage infiltration and tumor microvascular density were histologically evaluated in 41 patients with EWS, and association with prognosis was examined using Kaplan-Meier survival analysis. In mouse EWS xenografts, TAMs expressed higher concentrations of cytokines including interleukin-6, keratinocyte-derived chemokine, and monocyte chemotactic protein-1. TAMs were more capable than normal monocytes of differentiating into tartrate-resistant acid phosphatasepositive giant cells. Depleting macrophages using liposome-encapsulated clodronate significantly inhibited development of EWS xenografts. In human EWS samples, higher levels of CD68-positive macrophages were associated with poorer overall survival. In addition, enhanced vascularity, increase in the amount of C-reactive protein, and higher white blood cell counts were also associated with poor prognosis and macrophage infiltration. TAMs seem to enhance the progression of EWS by stimulating both angiogenesis and osteoclastogenesis. Further investigation of the behavior of TAMs may lead to development of biologically targeted therapies for EWS.
AB - Ewing sarcomaprimitive neuroectodermal tumor (EWS) is associated with the most unfavorable prognosis of all primary musculoskeletal tumors. The objective of the present study was to investigate whether tumor-associated macrophages (TAMs) affect the development of EWS. TAMs were isolated from mouse xenografts using CD11b magnetic beads and examined for their cytokine expression and osteoclastic differentiation. To evaluate the role of TAMs in xenograft formation, liposome-encapsulated clodronate was used to deplete TAMs in mice. Macrophage infiltration and tumor microvascular density were histologically evaluated in 41 patients with EWS, and association with prognosis was examined using Kaplan-Meier survival analysis. In mouse EWS xenografts, TAMs expressed higher concentrations of cytokines including interleukin-6, keratinocyte-derived chemokine, and monocyte chemotactic protein-1. TAMs were more capable than normal monocytes of differentiating into tartrate-resistant acid phosphatasepositive giant cells. Depleting macrophages using liposome-encapsulated clodronate significantly inhibited development of EWS xenografts. In human EWS samples, higher levels of CD68-positive macrophages were associated with poorer overall survival. In addition, enhanced vascularity, increase in the amount of C-reactive protein, and higher white blood cell counts were also associated with poor prognosis and macrophage infiltration. TAMs seem to enhance the progression of EWS by stimulating both angiogenesis and osteoclastogenesis. Further investigation of the behavior of TAMs may lead to development of biologically targeted therapies for EWS.
UR - http://www.scopus.com/inward/record.url?scp=80052839972&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=80052839972&partnerID=8YFLogxK
U2 - 10.1016/j.ajpath.2011.05.034
DO - 10.1016/j.ajpath.2011.05.034
M3 - Article
C2 - 21771572
AN - SCOPUS:80052839972
SN - 0002-9440
VL - 179
SP - 1157
EP - 1170
JO - American Journal of Pathology
JF - American Journal of Pathology
IS - 3
ER -